- Home
- MNKD vs MLKN Comparison
MNKD vs MLKN Comparison
Compare MNKD & MLKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- MLKN
- Stock Information
- Founded
- MNKD 1991
- MLKN 1905
- Country
- MNKD United States
- MLKN United States
- Employees
- MNKD N/A
- MLKN N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- MLKN Office Equipment/Supplies/Services
- Sector
- MNKD Health Care
- MLKN Consumer Discretionary
- Exchange
- MNKD Nasdaq
- MLKN Nasdaq
- Market Cap
- MNKD 1.8B
- MLKN 1.8B
- IPO Year
- MNKD 2004
- MLKN N/A
- Fundamental
- Price
- MNKD $6.22
- MLKN $25.52
- Analyst Decision
- MNKD Strong Buy
- MLKN
- Analyst Count
- MNKD 5
- MLKN 0
- Target Price
- MNKD $8.40
- MLKN N/A
- AVG Volume (30 Days)
- MNKD 2.8M
- MLKN 539.7K
- Earning Date
- MNKD 11-07-2024
- MLKN 12-18-2024
- Dividend Yield
- MNKD N/A
- MLKN 2.96%
- EPS Growth
- MNKD N/A
- MLKN 105.74
- EPS
- MNKD 0.08
- MLKN 0.88
- Revenue
- MNKD $267,200,000.00
- MLKN $3,572,200,000.00
- Revenue This Year
- MNKD $45.36
- MLKN $4.04
- Revenue Next Year
- MNKD $16.99
- MLKN $4.16
- P/E Ratio
- MNKD $74.80
- MLKN $28.80
- Revenue Growth
- MNKD 51.35
- MLKN N/A
- 52 Week Low
- MNKD $3.17
- MLKN $22.35
- 52 Week High
- MNKD $7.63
- MLKN $31.73
- Technical
- Relative Strength Index (RSI)
- MNKD 38.90
- MLKN 53.78
- Support Level
- MNKD $5.81
- MLKN $24.30
- Resistance Level
- MNKD $6.77
- MLKN $25.72
- Average True Range (ATR)
- MNKD 0.25
- MLKN 0.73
- MACD
- MNKD -0.07
- MLKN -0.02
- Stochastic Oscillator
- MNKD 36.44
- MLKN 59.04
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About MLKN MillerKnoll Inc.
MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract , International Contract & Specialty International & Specialty and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.